Jeff Daugherty Psychologist Medicare: Not Enrolled in Medicare Practice Location: 118 Maupin Cir, Shelbyville, TN 37160 Phone: 931-680-7576 Fax: 931-536-4346 |
Mr. Tim K Mcconkey, M.ED. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Spring St, Shelbyville, TN 37160 Phone: 931-684-6200 Fax: 931-684-3377 |
Dr. Raymond R Tesauro, ED.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 107 Holland St, Shelbyville, TN 37160 Phone: 931-680-4370 Fax: 931-680-4370 |
Dr. Robert M North Sr., ED.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 118 Maupin Cir, Shelbyville, TN 37160 Phone: 931-680-7576 Fax: 931-536-4346 |
Dr. Jacqueline Chapman North, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 118 Maupin Cir, Shelbyville, TN 37160 Phone: 931-680-7576 Fax: 931-536-4346 |
Glenn Johnson Psychologist - Counseling Medicare: Accepting Medicare Assignments Practice Location: 118 Maupin Cir, Shelbyville, TN 37160 Phone: 931-680-7576 Fax: 931-536-4346 |
News Archive
Janssen, a pharmaceutical company of Johnson & Johnson, is celebrating being ranked number 30 out of 100 Best Companies to Work for and being awarded the highest three star Best Companies Accreditation in research conducted by Best Companies in the UK and published by the Sunday Times.
Two brain areas fail to connect when children with attention deficit hyperactivity disorder attempt a task that measures attention, according to researchers at the UC Davis Center for Mind and Brain and M.I.N.D. Institute.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced the U.S. launch of its award-winning CASCADIA Interbody Systems, featuring Lamellar 3D Titanium Technology, during the 31st North American Spine Society (NASS) Annual Meeting, Oct. 26-29, 2016, in Boston at Booth #1615.
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Individuals at risk for Alzheimer's disease (AD) because of family history or genetic predisposition who engaged in six months of aerobic exercise training improved their brain glucose metabolism and higher-order thinking abilities (e.g., planning and mental flexibility) called executive function; these improvements occurred in conjunction with increased cardiorespiratory fitness.
› Verified 7 days ago